Active ingredientFosdenopterinCat. No. P-F119-001CAS 150829-29-1Family · Pharmaceutical analytical standards
Fosdenopterin
It supplies cPMP (cyclic pyranopterin monophosphate), the molecule that patients with molybdenum cofactor deficiency type A cannot make; approved in the United States in 2021, it is the first medicine for this very rare genetic disease. This family brings together the active ingredient.
Did you know?It was developed in Germany, at TU Braunschweig and the University of Cologne: cPMP is needed to build the cofactor that contains molybdenum, a metal essential to several enzymes.
Go to the active ingredient →Active ingredientFosdenopterinCat. No. P-F119-001CAS 150829-29-1No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.